We are funding the only
research chair in Canada
We need your support
Research Group >
Research Grants >

Research Grants

LIST OF MAJOR
RESEARCH GRANTS* 

Scleroderma Quebec’s financial contribution made possible the set up of the only Scleroderma Research Chair in Canada, whose financial support depends for the most part on Scleroderma Quebec.

To this date, Scleroderma Quebec has contributed over $2,600,000 to research.

2018
Financial support to the CHUM Research Centre for the purchase of the best version of the BD FACSymphony High Speed Analyzer system.  This cutting-edge high parameter flow cytometer, of unparallelled capabilities enables the simultaneous measurement of up to 50 different characteristics of a single cell.  This novel cell analyser, worth close to one and a half million dollars, still has a very limited distribution in North America.  The BD FACSymphony will be used primarily by the scleroderma research Chair and will also be made available to all medical research teams at the CHUM Research Centre who are impatiently awaiting it.
Grant amount: $400,000

2018-2022
Scleroderma Patient-centered Intervention Network (SPIN/RIPS)
Financial support of the SPIN-SHARE project
Grant amount: $50,000

2017
CHUM Scleroderma Research Chair-related subscription fund
Chairholder: Jean-Luc Senécal, M.D.
Grant amount: $100,000

2015
Scleroderma Research Group of the CHUM (SRG-CHUM)
Research fund – Martial Koenig, M. D.
Grant amount: $15,000

2014
Scleroderma Research Group of the CHUM (SRG-CHUM)
Research fund – Martial Koenig, M. D.
Grant amount: $15,000

2011-2012
Scleroderma Research Group of the CHUM (SRG-CHUM)
Principal investigator: Jean-Luc Senécal, M.D.
Research Project related to the work of the Scleroderma Research Chair of the Université de Montréal 
Grant amount: $300,000

2010-2012
Canadian Scleroderma Research Group (GRCS),
McGill University and Montreal’s Jewish General Hospital
Principal investigator : Brett D. Thombs, Ph.D.
Research Project : Consortium for clinical trials of behavioral, psychological, and educational interventions in scleroderma: Initial planning meeting & Coordinator for the Scleroderma Patient-centered Intervention Network.
Grant amount : 8 000 $

2009-2011
Scleroderma Research Group of the CHUM (SRG-CHUM)
Establishment grant for Martial Koenig, M.D. (recruitment of a multidisciplinary team for the SRG-CHUM).
Grant amount: $150,000

2007-2012
Canadian Scleroderma Research Group (CSRG)
Principal investigator: Murray Baron, M.D.,  Montreal’s Jewish General Hospital
Research Project: Establishment of a pan-Canadian multicenter registry of scleroderma patients
Grant amount: $40,000

2007-2010
SRG-CHUM
Principal investigator: Jean-Luc Senécal, M.D.
Research Project: The pathologic role of autoantibodies in scleroderma lung disease Chair 
Grant amount: $252,000

2002
CHUM Scleroderma Research Group (SRG-CHUM)
Principal investigator: Jean-Luc Senécal, M.D.
Research Project: Anticentomere autoantibodies in scleroderma lung Disease
Grant amount: $16,000

 * during the period from 2000 onwards.

Scleroderma Quebec’s fellowships
to students under the supervision of 
Dr. Jean-Luc Senécal, SRG-CHUM:

2007-2009  
Master’s Scholarship
Amount: $35,700
Karine Beauchemin, B.Sc., M.Sc. candidate, Department of Biomedical Sciences, Université de Montréal.
Research Project: Molecular and cellular characterization of topoisomerase DNA interaction with the cell surface of fibroblasts.

2005-2006
Master’s Scholarship
Amount: $17,850
Karine Lamy, B.Sc., M.Sc. candidate, Department of Biomedical Sciences, Université de Montréal.
Research Project: Characterization of the binding of the centromeric protein CENP-B to smooth muscle cells and its relevance to scleroderma.

2004-2006
Fellowship Award        
Amount: $50,000
Martial Koenig, M. D. hospital assistant specialist (internal medicine)
University Hospital of Saint-Etienne, France.
Research projects: Autoantibodies in autoimmune myositis in French Canadians
Diagnostic and prognostic value of autoantibodies in isolated Raynaud’s phenomenon and systemic sclerosis in French Canadians.

2003-2008
Doctoral Fellowship 
Amount: $90,000 
Geneviève Robitaille, M.Sc., Ph.D. candidate, Department of Biomedical Sciences, Université de Montréal.
Research Project: The role of autoantibodies directed against centromere protein B in the pathophysiology of systemic sclerosis.

2003-2006
Doctoral Fellowship 
Amount: $54,000
Julie Arcand, B.Sc., Ph.D. candidate, Department of Biomedical Sciences, Université de Montréal.
Research Project: Characterization of the interaction of autoantibodies anti-DNA topoisomerases with fibroblasts in systemic sclerosis.

2002-2005
Doctoral Fellowship
Amount: $45,000
Jill Hénault, M.Sc., Ph. D. candidate, Department of Biomedical Sciences, Université de Montréal.
Research Project: The role of anti-fibroblast autoantibodies in triggering and sustaining the autoimmune cascade and its fibrogenic consequences.

2002-2004
Master’s Scholarship
Amount: $26,000
Mélanie Tremblay, B.Sc. (Biochemistry), M.Sc. candidate, Department of Biomedical Sciences, Université de Montréal.
Research Project: Identification and characterization of a new fibroblast autoantigen involved in scleroderma.

 

THE SCLERODERMA RESEARCH CHAIR

In 2005, Scleroderma Quebec has pledged a total of $1 million to the Scleroderma Research Chair of the Université de Montréal in support of scleroderma research. 

These are the amounts paid to date by Scleroderma Quebec to the Chair: $100,000 (April 30, 2005), $150,000 (November 18, 2005), $187,500 (November 21, 2006), $93,750 (January 4, 2008), $93,750 (November 27, 2008), $93,750 (December 1st, 2009), $25,000 (October 2016), $25,000 (July 2017) and $31,250 (August 2018) totalizing $800,000.

As of April 30, 2018, the fair market value of this endowed Chair is $1,589,701.

 

DISCOVER OUR WEBSITE
BECOME A
MEMBER AND
RECEIVE THE
NEWSLETTER
CLICK HERE
challenge to beat scleroderma through fundraising for research